跳至主要内容
临床试验/NCT06170736
NCT06170736招募中不适用

Radiofrequency Haemorrhoidal Thermoablation Versus Doppler-guided Haemorrhoidal Artery Ligation With Mucopexy in the Treatment of Haemorrhoidal Disease: a Multicenter Randomized Non-inferiority Trial

Centre Hospitalier Departemental Vendee20 个研究点 分布在 1 个国家目标入组 168 人开始时间: 2024年2月21日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
168
试验地点
20
主要终点
Failure rate at one year post-operatively

研究概览

简要总结

Surgical treatment of grade II/III internal haemorrhoidal disease is indicated in the case of medical and/or instrumental treatment failure. Minimal invasive alternatives to haemorrhoidectomy have been introduced in the last decades to treat grade II/III haemorrhoids. Doppler-Guided haemorrhoidal artery ligation (DGHAL) represents a good therapeutic option in this condition with good short and mid-term outcomes but postoperative recurrence rates up to 35% at 5 years.

Recently, a technique of radiofrequency ablation (RFA) has been introduced with promising outcomes. A recent systematic review reported a significant improvement of preoperative symptoms and a recurrence rate < 5%.

To date, there is no study comparing DGHAL to RFA in the treatment of grade II/III haemorrhoids.

The aim of this study is to demonstrate the non-inferiority in terms of failure rate of haemorrhoidal radiofrequency ablation compared to Doppler-guided haemorrhoidal artery ligation, associated with mucopexy, in the treatment of grade II and III haemorrhoidal disease

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Major patient,
  • With symptomatic Grade II or III haemorrhoidal disease,
  • Requiring surgical management,
  • Patient able to understand the protocol and having given written informed consent to participate in the study,
  • Patient affiliated to the social security system or entitled to it.

排除标准

  • Hemostasis disorders
  • Active external haemorrhoidal disease (thrombosis)
  • History of surgical procedure for treatment of haemorrhoids (instrumental treatment is not a contra-indication)
  • Associated proctological pathology (anal fissure, chronic suppuration, external rectal prolapse)
  • History of colorectal cancer
  • History of inflammatory bowel disease
  • History of rectal resection
  • Patient participating in another interventional clinical research protocol involving a drug or clinical investigation of a medical device
  • Patient who is pregnant, breastfeeding or able to procreate without effective contraception* at the time of inclusion
  • Patient under guardianship, curators or deprived of liberty.
  • Patient under court protection.
  • oral contraceptive (pill), monthly vaginal ring, weekly transdermal patch, subcutaneous implant, intrauterine devices (IUD), or sterilisation.

研究组 & 干预措施

Radiofrequency Ablation

Experimental

Patients will be treated by radiofrequency ablation.

干预措施: Radiofrequency ablation (Procedure)

Doppler-Guided Haemorrhoidal Artery Ligation

Active Comparator

Patients will be treated by DGHAL procedure.

干预措施: Doppler-Guided Haemorrhoidal Artery Ligation (Procedure)

结局指标

主要结局

Failure rate at one year post-operatively

时间窗: one year post-operatively

The evaluation of failure rate will be based on the calculation of the HDSS score grouping the different symptoms (pain, discomfort, bleeding, soiling and prolapse). Failure rate will be defined by a score greater than or equal to the preoperative score or by a reoperation (surgical or instrumental) for relapse of the symptoms.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (20)

Loading locations...

相似试验